Tengion Inc (TNGN) Financial Statements (2025 and earlier)

Company Profile

Business Address 3929 WESTPOINT BLVD.
WINSTON-SALEM, NC 27103
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,124,00015,366,00021,510,00027,479,00013,873,0002,857,000
Cash and cash equivalent10,124,00015,366,00021,510,00027,479,00013,873,0002,857,000
Restricted cash and investments      1,001,000
Receivables     20,626,000 
Prepaid expense485,000     
Prepaid expense and other current assets295,000334,000418,000476,000296,000
Total current assets:10,609,00015,661,00021,844,00027,897,00034,975,0004,154,000
Noncurrent Assets
Property, plant and equipment511,000463,000454,000410,000467,000529,000
Other noncurrent assets3,077,000     
Prepaid expense and other noncurrent assets3,217,0003,426,0003,570,0003,528,0002,944,000
Total noncurrent assets:3,588,0003,680,0003,880,0003,980,0003,995,0003,473,000
TOTAL ASSETS:14,197,00019,341,00025,724,00031,877,00038,970,0007,627,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,709,0002,640,0003,976,0003,850,0004,999,0002,115,000
Interest and dividends payable781,000     
Employee-related liabilities460,000252,000757,000624,000427,000218,000
Accounts payable661,000799,000853,0001,329,0001,889,000367,000
Accrued liabilities1,807,0001,589,0002,366,0001,897,0002,683,0001,530,000
Debt675,0001,008,0001,994,0002,824,0004,061,0003,245,000
Derivative instruments and hedges, liabilities      2,786,000
Other undisclosed current liabilities45,759,00035,663,00010,668,00022,751,00021,010,0006,038,000
Total current liabilities:50,143,00039,311,00016,638,00029,425,00030,070,00014,184,000
Noncurrent Liabilities
Long-term debt and lease obligation29,910,00028,917,00025,930,00026,249,00025,399,0009,653,000
Long-term debt, excluding current maturities29,727,00028,669,00025,623,00025,886,00024,980,0009,178,000
Capital lease obligations183,000248,000307,000363,000419,000475,000
Liabilities, other than long-term debt12,00012,00012,00012,00011,00010,000
Other liabilities12,00012,00012,00012,00011,00010,000
Total noncurrent liabilities:29,922,00028,929,00025,942,00026,261,00025,410,0009,663,000
Total liabilities:80,065,00068,240,00042,580,00055,686,00055,480,00023,847,000
Equity
Equity, attributable to parent, including:(65,868,000)(48,899,000)(16,856,000)(23,809,000)(16,510,000)(16,220,000)
Common stock22,00018,0007,0004,0003,0003,000
Additional paid in capital252,323,000251,441,000249,237,000248,326,000248,369,000236,724,000
Accumulated deficit(318,213,000)(300,358,000)(266,100,000)(272,139,000)(264,882,000)(252,947,000)
Warrants and rights outstanding47,000,00035,915,00011,425,00022,751,00021,010,0006,038,000
Other undisclosed equity, attributable to parent(47,000,000)(35,915,000)(11,425,000)(22,751,000)(21,010,000)(6,038,000)
Total equity:(65,868,000)(48,899,000)(16,856,000)(23,809,000)(16,510,000)(16,220,000)
TOTAL LIABILITIES AND EQUITY:14,197,00019,341,00025,724,00031,877,00038,970,0007,627,000

Income Statement (P&L) (USD)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Operating expenses(4,809,000)(4,409,000)(4,472,000)(3,904,000)(4,078,000)(4,143,000)
Other operating income (expense), net
(Other Expenses)
(151,000)153,000278,000156,00091,00030,000
Operating loss:(4,960,000)(4,256,000)(4,194,000)(3,748,000)(3,987,000)(4,113,000)
Nonoperating income
(Investment Income, Nonoperating)
5,0009,00021,00019,0002,0005,000
Interest and debt expense(1,881,000)(1,964,000)(2,119,000)(2,246,000)(1,830,000)(1,427,000)
Other undisclosed income from continuing operations before equity method investments, income taxes2,027,0001,802,0001,820,0002,071,0001,737,0001,392,000
Loss from continuing operations:(4,809,000)(4,409,000)(4,472,000)(3,904,000)(4,078,000)(4,143,000)
Loss before gain (loss) on sale of properties:(4,809,000)(4,409,000)(4,472,000)(3,904,000)(4,078,000)(4,143,000)
Net loss:(4,809,000)(4,409,000)(4,472,000)(3,904,000)(4,078,000)(4,143,000)
Other undisclosed net income (loss) attributable to parent(13,046,000)(29,849,000)10,511,000(3,353,000)(5,562,000)(1,631,000)
Net income (loss) available to common stockholders, diluted:(17,855,000)(34,258,000)6,039,000(7,257,000)(9,640,000)(5,774,000)

Comprehensive Income (USD)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Net loss:(4,809,000)(4,409,000)(4,472,000)(3,904,000)(4,078,000)(4,143,000)
Comprehensive loss:(4,809,000)(4,409,000)(4,472,000)(3,904,000)(4,078,000)(4,143,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(13,046,000)(29,849,000)10,511,000(3,353,000)(7,857,000)(1,631,000)
Comprehensive income (loss), net of tax, attributable to parent:(17,855,000)(34,258,000)6,039,000(7,257,000)(11,935,000)(5,774,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: